Green Light, Yellow Light, Red Light, STOPP: Learning What Medications to Avoid in Geriatrics

Document Type


Publication Date



ACPE # 0079-9999-14-130-H05-P

Expiration Date: 01/28/2016

Knowledge Based Activity; eligible for 1 Contact Hour

The following knowledge-based CPE programs have been developed in conjunction with The Jefferson School of Population Health and Department of Pharmacy of Thomas Jefferson University Hospital. The programs are free to all Jefferson pharmacists.

Method & Format

Each online program consists of audio with slides. After viewing the online course, contact Melissa Horowitz at Melissa.horowitz@jefferson.edu to receive the post-test and activity evaluation.

A minimum score of 70% is required on the test for credit to be awarded. The estimated time to complete this activity is 1 hour. Participants who successfully complete will be awarded 1.00 hours of continuing pharmacy education credit (.100 CEUs).

Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live activity.

Target Audience

This continuing pharmacy education activity was planned to meet the needs of Jefferson pharmacists in a variety of practice settings, including large and small health systems, managed-care organizations, and academia.

System Requirements

Please ensure that the computer you plan to use meets the following requirements:

  • Operating System: Microsoft Windows, Apple Mac OS X, Apple iOS (iPad)
  • Supported Browsers: Google Chrome (recommended), Mozilla Firefox and Apple Safari
  • Internet Connection: Broadband recommended

Please contact the ACPE administrator at (215) 955-9817 with any questions pertaining to these programs.



  • Review the epidemiology of polypharmacy within the geriatric population
  • Understand patient parameters that put geriatric patients at risk for adverse effects
  • Describe the purpose of Beers Criteria and START/STOPP
  • Identify the leading culprits of unsafe medication use in the elderly population
  • Given a clinical scenario, determine safer alternatives for treatment in geriatrics, including non-pharmacologic management